Akebia Therapeutics (AKBA) Current Leases (2013 - 2020)
Akebia Therapeutics (AKBA) reported Current Leases of $5.1 million for Q1 2020, down 83.72% year-over-year from $31.3 million in Q2 2019, and up 2.14% quarter-over-quarter from $5.0 million in Q4 2019.
Akebia Therapeutics (AKBA) Current Leases (2013 - 2020) Analysis & Trends
Akebia Therapeutics (AKBA) has 4 years of Current Leases data on file, last reported at $5.1 million in Q1 2020.
- Current Leases for Q1 2020 came in at $5.1 million, down 83.72% year-over-year; the trailing twelve-month figure through Mar 2020 was $5.1 million (down 83.72% YoY), and the FY2019 annual result was $5.0 million, changed N/A from the prior year.
- Current Leases rose to $5.1 million in Q1 2020 per AKBA's latest filing, from $5.0 million in the prior quarter.
- Over five years, Current Leases peaked at $31.3 million in Q1 2019 and troughed at $4.8 million in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 23.81 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 7.58 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 5.58 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Akebia Therapeutics | 243.23 Mn | 80.63 Mn | 41.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 5.10 Mn |
| Dec 31, 2019 | 4.99 Mn |
| Sep 30, 2019 | 4.88 Mn |
| Jun 30, 2019 | 4.78 Mn |
| Mar 31, 2019 | 31.30 Mn |
| Jun 30, 2014 | 3,939.00 |
| Mar 31, 2014 | 3,911.00 |
| Dec 31, 2013 | 3,912.00 |